Get started
Author

Maksym Chernenko

Observed names: M Chernenko, M. Chernenko, M. E. Chernenko, M.E. Chernenko, M.Ye. Chernenko, Maksim Yevgenevich Chernenko, Maksym Ye. Chernenko, Maksym СHERNENKO, Maxim Chernenko, Maxim E. Chernenko
ORCID: 0000-0002-7810-792X
Observed ORCID: 0000-0002-7810-792X
OpenAlex ID: A5086049035
Modern Pulse Corticosteroid Therapy in Patients with Multiple Sclerosis: Adverse Events and Clinical and Pharmacological Measures to Eliminate Them
2025 · Maksym Chernenko, Tetiana Nehreba, et al. · SSP Modern Pharmacy and Medicine · 20
PDF
Modern Experience of Pharmacotherapeutic Use and Effectiveness of Endolumbal Administration of Glucocorticoids in Progressive Types of Course for Multiple Sclerosis
2024 · Vitaliy Vasylovskyy, Tetiana Nehreba, et al. · SSP Modern Pharmacy and Medicine · 19
Application of Glucocorticoids in Therapy of Multiple Sclerosis
2024 · Vitaliy Vasylovskyy, Tetiana Nehreba, et al. · SSP Modern Pharmacy and Medicine · 16
PDF
Relevance of Impact of Non-Drug Methods on Neuroplasticity in System of Neurorehabilitation: Multilevel Neuroplastic Effects of Electromagnetic Fields Caused by Transcranial Magnetic Stimulation
2025 · Maksym Chernenko, Tetiana Nehreba, et al. · SSP Modern Pharmacy and Medicine · 8
PDF
Study of the Level of Matrix Metalloproteinase-9 as an Indicator of Activity of Inflammatory Process Among Patients Suffering from Multiple Sclerosis
2025 · Maksym Chernenko, Nataliya Voloshyna, et al. · SSP Modern Pharmacy and Medicine · 7
PDF
Formation of the forecast character depending on the ways of development of the progression stage and progression options in progredient types of multiple sclerosis
2021 · Natalia Voloshyna, Tetiana Litovchenko, et al. · Ukrains kyi Visnyk Psykhonevrolohii · 7
PDF
Correlation analysis between clinical indicators in different types of multiple sclerosis
2022 · Natalia Voloshyna, Vitalii Vasylovskyi, et al. · Ukrains kyi Visnyk Psykhonevrolohii · 6
PDF
Comparative Mathematical Analysis Based on the Data History of Nonhereditary Risk and Anti-risk Factors Between Patients With Sporadic and Familial Forms of Multiple Sclerosis
2023 · Tatyana NEGREBA, Natalia VOLOSHYNA, et al. · Ukrains kyi Visnyk Psykhonevrolohii · 1
PDF
Клинико-математический анализ различий для разных типов течения при спорадической и семейной формах рассеянного склероза
2020 · N.P. Voloshyna, T.V. Nehreba, et al. · INTERNATIONAL NEUROLOGICAL JOURNAL · 1
PDF
Cognitive Impairment in Neurodegenerative Pathology as Index of Neuroplasticity in Psychoneurological Model of Adaptation of Patients
2020 · Maksim Yevgenevich Chernenko · International Medical Journal · 1
Matrix Metalloproteinase-9 and Inflammation in Different Types of Multiple Sclerosis
2016 · Nataliya Voloshyna, Vitaliy Vasylovskyy, et al. · EUREKA Health Sciences · 1
PDF
PSYCHO-EMOTIONAL DISORDERS IN DIFFERENT TYPES OF MULTIPLE SCLEROSIS DURING THE PERIOD OF MILITARY HOSTILITIES IN UKRAINE (clinical-mathematical analysis)*
2025 · Tatyana NEGREBA, Valery KIRZHNER, et al. · Ukrains kyi Visnyk Psykhonevrolohii
PDF
PATHOMORPHOSIS OF DIFFERENT TYPES OF MULTIPLE SCLEROSIS DURING THE PERIOD OF MILITARY HOSTILITIES IN UKRAINE (clinical-mathematical analysis)
2025 · Tatyana NEGREBA, Valery KIRZHNER, et al. · Ukrains kyi Visnyk Psykhonevrolohii
PDF
Pulse Therapy With Corticosteroids in Patients With Multiple Sclerosis: Adverse Events and Ways to Overcome Them
2024 · Vitalii Vasylovskyi, Natalia Voloshyna, et al. · Ukrains kyi Visnyk Psykhonevrolohii
PDF
Efficacy of Glucocorticoid Therapy in Different Types of Multiple Sclerosis Progression
2024 · Vitaliy Vasylovskyy, Tetiana Nehreba, et al. · IntechOpen eBooks
PDF
Comparative Assessment of the Content of Antibody Titres to Double-stranded Dna and the Prevalence of Aa, Ag Haplotypes Between Patients With Sporadic and Familial Forms of Multiple Sclerosis and Practically Healthy Children With the Help of Mathematical Analysis (third Part)
2023 · Tatyana NEGREBA, Valery KIRZHNER, et al. · Ukrains kyi Visnyk Psykhonevrolohii
PDF
Clinical and Mathematical Analysis of the Features of the Course of Multiple Sclerosis in Patients With Sporadic and Familial Forms (fourth Part)
2023 · Tatyana NEGREBA, Valery KIRZHNER, et al. · Ukrains kyi Visnyk Psykhonevrolohii
PDF
Comparative mathematical analysis of nonhereditary risk and anti-risk factors between patients with multiple sclerosis and their practically healthy children based on anamnesis data
2023 · Tetiana Negreba, Natalia Voloshyna, et al. · Ukrains kyi Visnyk Psykhonevrolohii
PDF
Formation of beneficial and pathological neuroplasticity depending on the nature of the prognosis in different types of the course in patients with sporadic and familial forms of multiple sclerosis
2023 · Tetiana Negreba, Natalia Voloshyna, et al. · Ukrains kyi Visnyk Psykhonevrolohii
PDF
Clinical and Immunogenetic Characteristic of Healthy Children Born to Multiple Sclerosis Patients
2022 · Tatyana NEGREBA, Natalia VOLOSHYNA, et al. · Ukrains kyi Visnyk Psykhonevrolohii
PDF
Protocol for the treatment of patients with multiple sclerosis using bone marrow stromal cells (BMSC) in the State Institution "Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine"
2022 · Natalia Voloshyna, Vitalii Vasylovskyi, et al. · Ukrains kyi Visnyk Psykhonevrolohii
PDF
Protocol for the treatment of patients with a spectrum of opiomyelitis-associated diseases using bone marrow stromal cells in the State Institution "Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine"
2022 · Natalia Voloshyna, Vitalii Vasylovskyi, et al. · Ukrains kyi Visnyk Psykhonevrolohii
PDF
Protocol for the treatment of patients with amyotrophic lateral sclerosis using bone marrow stromal cells in the State Institution "Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine"
2022 · Natalia Voloshyna, Vitalii Vasylovskyi, et al. · Ukrains kyi Visnyk Psykhonevrolohii
PDF
Значення часових етапів при різних типах перебігу розсіяного склерозу для формування прогнозу
2021 · N.P. Voloshyna, V.V. Vasylovskyy, et al. · INTERNATIONAL NEUROLOGICAL JOURNAL
PDF
Evaluation of Cognitive Functions in Neurodegeneration
2020 · Maxim Chernenko · Technology transfer innovative solutions in medicine
PDF
Works count: 39
Citation count: 87
H-index: 6
I10-index: 3
Year
Topic
Type